ID   GLYM_HUMAN              Reviewed;         504 AA.
AC   P34897; B7Z9F1; E7EQ19; E7EU43; O00740; Q8N1A5;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 3.
DT   10-MAY-2017, entry version 182.
DE   RecName: Full=Serine hydroxymethyltransferase, mitochondrial;
DE            Short=SHMT;
DE            EC=2.1.2.1 {ECO:0000269|PubMed:24075985, ECO:0000269|PubMed:25619277};
DE   AltName: Full=Glycine hydroxymethyltransferase;
DE   AltName: Full=Serine methylase;
DE   Flags: Precursor;
GN   Name=SHMT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Lymph, Muscle, Ovary, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-35.
RX   PubMed=10828359; DOI=10.1016/S0065-2571(99)00035-7;
RA   Snell K., Baumann U., Byrne P.C., Chave K.J., Renwick S.B.,
RA   Sanders P.G., Whitehouse S.K.;
RT   "The genetic organization and protein crystallographic structure of
RT   human serine hydroxymethyltransferase.";
RL   Adv. Enzyme Regul. 40:353-403(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 22-504.
RX   PubMed=8999870; DOI=10.1074/jbc.272.3.1842;
RA   Stover P.J., Chen L.H., Suh J.R., Stover D.M., Keyomarsi K., Shane B.;
RT   "Molecular cloning, characterization, and regulation of the human
RT   mitochondrial serine hydroxymethyltransferase gene.";
RL   J. Biol. Chem. 272:1842-1848(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 31-504 (ISOFORM 1).
RX   PubMed=8505317;
RA   Garrow T.A., Brenner A.A., Whitehead M.V., Chen X.-N., Duncan R.G.,
RA   Korenberg J.R., Shane B.;
RT   "Cloning of human cDNAs encoding mitochondrial and cytosolic serine
RT   hydroxymethyltransferases and chromosomal localization.";
RL   J. Biol. Chem. 268:11910-11916(1993).
RN   [9]
RP   SUBCELLULAR LOCATION, FUNCTION IN ASSOCIATION WITH MITOCHONDRIAL DNA,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18063578; DOI=10.1074/jbc.M708444200;
RA   Bogenhagen D.F., Rousseau D., Burke S.;
RT   "The layered structure of human mitochondrial DNA nucleoids.";
RL   J. Biol. Chem. 283:3665-3675(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-103; LYS-181; LYS-196;
RP   LYS-297; LYS-356; LYS-464; LYS-469 AND LYS-474, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=21876188; DOI=10.1073/pnas.1103623108;
RA   Anderson D.D., Quintero C.M., Stover P.J.;
RT   "Identification of a de novo thymidylate biosynthesis pathway in
RT   mammalian mitochondria.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:15163-15168(2011).
RN   [13]
RP   IDENTIFICATION IN THE BRISC COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, INTERACTION WITH FAM175B, CATALYTIC ACTIVITY,
RP   IDENTIFICATION IN A COMPLEX WITH FAM175B AND INAR1, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=24075985; DOI=10.1016/j.celrep.2013.08.025;
RA   Zheng H., Gupta V., Patterson-Fortin J., Bhattacharya S.,
RA   Katlinski K., Wu J., Varghese B., Carbone C.J., Aressy B., Fuchs S.Y.,
RA   Greenberg R.A.;
RT   "A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon
RT   responses.";
RL   Cell Rep. 5:180-193(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-470, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   INTERACTION WITH KIRREL3.
RX   PubMed=25902260; DOI=10.1371/journal.pone.0123106;
RA   Liu Y.F., Sowell S.M., Luo Y., Chaubey A., Cameron R.S., Kim H.G.,
RA   Srivastava A.K.;
RT   "Autism and intellectual disability-associated KIRREL3 interacts with
RT   neuronal proteins MAP1B and MYO16 with potential roles in
RT   neurodevelopment.";
RL   PLoS ONE 10:E0123106-E0123106(2015).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.04 ANGSTROMS) OF 17-504.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human mitochondrial serine
RT   hydroxymethyltransferase 2.";
RL   Submitted (OCT-2010) to the PDB data bank.
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 22-504, FUNCTION, CATALYTIC
RP   ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND COFACTOR.
RX   PubMed=25619277; DOI=10.1111/febs.13211;
RA   Giardina G., Brunotti P., Fiascarelli A., Cicalini A., Costa M.G.,
RA   Buckle A.M., di Salvo M.L., Giorgi A., Marani M., Paone A.,
RA   Rinaldo S., Paiardini A., Contestabile R., Cutruzzola F.;
RT   "How pyridoxal 5'-phosphate differentially regulates human cytosolic
RT   and mitochondrial serine hydroxymethyltransferase oligomeric state.";
RL   FEBS J. 282:1225-1241(2015).
CC   -!- FUNCTION: Contributes to the de novo mitochondrial thymidylate
CC       biosynthesis pathway via its role in glycine and tetrahydrofolate
CC       metabolism. Thymidylate biosynthesis is required to prevent uracil
CC       accumulation in mtDNA (PubMed:21876188). Interconversion of serine
CC       and glycine (PubMed:25619277). Associates with mitochondrial DNA
CC       (PubMed:18063578). Plays a role in the deubiquitination of target
CC       proteins as component of the BRISC complex (PubMed:24075985).
CC       Required for IFNAR1 deubiquitination by the BRISC complex
CC       (PubMed:24075985). {ECO:0000269|PubMed:18063578,
CC       ECO:0000269|PubMed:21876188, ECO:0000269|PubMed:24075985,
CC       ECO:0000269|PubMed:25619277}.
CC   -!- CATALYTIC ACTIVITY: 5,10-methylenetetrahydrofolate + glycine +
CC       H(2)O = tetrahydrofolate + L-serine. {ECO:0000269|PubMed:24075985,
CC       ECO:0000269|PubMed:25619277}.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:25619277};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=278 uM for L-serine {ECO:0000269|PubMed:25619277};
CC         KM=23 uM for tetrahydrofolate {ECO:0000269|PubMed:25619277};
CC   -!- PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion.
CC       {ECO:0000305|PubMed:25619277}.
CC   -!- SUBUNIT: Homotetramer; in the presence of bound pyridoxal 5'-
CC       phosphate. Homodimer; in the absence of bound pyridoxal 5'-
CC       phosphate. Pyridoxal 5'-phosphate binding mediates an important
CC       conformation change that is required for tetramerization
CC       (PubMed:25619277). Interacts with FAM175B; the interaction is
CC       direct. Identified in a complex with FAM175B and the other
CC       subunits of the BRISC complex, at least composed of the
CC       FAM175B/ABRO1, BRCC3/BRCC36, BRE/BRCC45 and BABAM1/NBA1.
CC       Identified in a complex with FAM175B and INAR1 (PubMed:24075985).
CC       Interacts with KIRREL3 (PubMed:25902260).
CC       {ECO:0000269|PubMed:24075985, ECO:0000269|PubMed:25619277,
CC       ECO:0000269|PubMed:25902260}.
CC   -!- INTERACTION:
CC       Q15041:ARL6IP1; NbExp=3; IntAct=EBI-352908, EBI-714543;
CC       Q96DZ9:CMTM5; NbExp=3; IntAct=EBI-352908, EBI-2548702;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:21876188,
CC       ECO:0000269|PubMed:24075985}. Mitochondrion matrix, mitochondrion
CC       nucleoid {ECO:0000269|PubMed:18063578}. Mitochondrion inner
CC       membrane {ECO:0000269|PubMed:21876188}. Cytoplasm
CC       {ECO:0000269|PubMed:24075985}. Nucleus
CC       {ECO:0000269|PubMed:24075985}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P34897-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P34897-2; Sequence=VSP_043088;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P34897-3; Sequence=VSP_043844;
CC   -!- MISCELLANEOUS: In eukaryotes there are two forms of the enzymes: a
CC       cytosolic one and a mitochondrial one.
CC   -!- SIMILARITY: Belongs to the SHMT family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK315916; BAH14287.1; -; mRNA.
DR   EMBL; BT006866; AAP35512.1; -; mRNA.
DR   EMBL; AC137834; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW96994.1; -; Genomic_DNA.
DR   EMBL; CH471054; EAW96998.1; -; Genomic_DNA.
DR   EMBL; BC011911; AAH11911.1; -; mRNA.
DR   EMBL; BC013677; AAH13677.1; -; mRNA.
DR   EMBL; BC032584; AAH32584.1; -; mRNA.
DR   EMBL; BC044211; AAH44211.1; -; mRNA.
DR   EMBL; Y12331; CAA72999.1; -; Genomic_DNA.
DR   EMBL; U23143; AAA64572.1; -; Genomic_DNA.
DR   EMBL; L11932; AAA63258.1; -; mRNA.
DR   CCDS; CCDS53805.1; -. [P34897-3]
DR   CCDS; CCDS55837.1; -. [P34897-2]
DR   CCDS; CCDS8934.1; -. [P34897-1]
DR   PIR; B46746; B46746.
DR   RefSeq; NP_001159828.1; NM_001166356.1. [P34897-2]
DR   RefSeq; NP_001159829.1; NM_001166357.1. [P34897-3]
DR   RefSeq; NP_001159830.1; NM_001166358.1. [P34897-3]
DR   RefSeq; NP_001159831.1; NM_001166359.1. [P34897-3]
DR   RefSeq; NP_005403.2; NM_005412.5. [P34897-1]
DR   UniGene; Hs.741179; -.
DR   PDB; 3OU5; X-ray; 2.04 A; A=17-504.
DR   PDB; 4PVF; X-ray; 2.60 A; A/B=22-504.
DR   PDBsum; 3OU5; -.
DR   PDBsum; 4PVF; -.
DR   ProteinModelPortal; P34897; -.
DR   SMR; P34897; -.
DR   BioGrid; 112368; 433.
DR   IntAct; P34897; 35.
DR   MINT; MINT-3013548; -.
DR   STRING; 9606.ENSP00000333667; -.
DR   DrugBank; DB00145; Glycine.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   DrugBank; DB00116; Tetrahydrofolic acid.
DR   iPTMnet; P34897; -.
DR   PhosphoSitePlus; P34897; -.
DR   SwissPalm; P34897; -.
DR   BioMuta; SHMT2; -.
DR   DMDM; 6226865; -.
DR   EPD; P34897; -.
DR   PaxDb; P34897; -.
DR   PeptideAtlas; P34897; -.
DR   PRIDE; P34897; -.
DR   DNASU; 6472; -.
DR   Ensembl; ENST00000328923; ENSP00000333667; ENSG00000182199. [P34897-1]
DR   Ensembl; ENST00000414700; ENSP00000406881; ENSG00000182199. [P34897-3]
DR   Ensembl; ENST00000449049; ENSP00000413770; ENSG00000182199. [P34897-3]
DR   Ensembl; ENST00000553474; ENSP00000452419; ENSG00000182199. [P34897-3]
DR   Ensembl; ENST00000557487; ENSP00000452315; ENSG00000182199. [P34897-2]
DR   GeneID; 6472; -.
DR   KEGG; hsa:6472; -.
DR   UCSC; uc001sni.3; human. [P34897-1]
DR   CTD; 6472; -.
DR   DisGeNET; 6472; -.
DR   GeneCards; SHMT2; -.
DR   HGNC; HGNC:10852; SHMT2.
DR   HPA; HPA020543; -.
DR   HPA; HPA020549; -.
DR   MIM; 138450; gene.
DR   neXtProt; NX_P34897; -.
DR   OpenTargets; ENSG00000182199; -.
DR   PharmGKB; PA35755; -.
DR   eggNOG; KOG2467; Eukaryota.
DR   eggNOG; COG0112; LUCA.
DR   GeneTree; ENSGT00390000002762; -.
DR   HOGENOM; HOG000239405; -.
DR   HOVERGEN; HBG002807; -.
DR   InParanoid; P34897; -.
DR   KO; K00600; -.
DR   OMA; MAIRCQH; -.
DR   OrthoDB; EOG091G05AU; -.
DR   PhylomeDB; P34897; -.
DR   TreeFam; TF314667; -.
DR   BioCyc; MetaCyc:HS00049-MONOMER; -.
DR   Reactome; R-HSA-196757; Metabolism of folate and pterines.
DR   UniPathway; UPA00193; -.
DR   ChiTaRS; SHMT2; human.
DR   EvolutionaryTrace; P34897; -.
DR   GenomeRNAi; 6472; -.
DR   PRO; PR:P34897; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000182199; -.
DR   CleanEx; HS_SHMT2; -.
DR   ExpressionAtlas; P34897; baseline and differential.
DR   Genevisible; P34897; HS.
DR   GO; GO:0070552; C:BRISC complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IEA:Ensembl.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:UniProtKB.
DR   GO; GO:0042645; C:mitochondrial nucleoid; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0016597; F:amino acid binding; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0004372; F:glycine hydroxymethyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0008732; F:L-allo-threonine aldolase activity; IEA:Ensembl.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB.
DR   GO; GO:0046655; P:folic acid metabolic process; TAS:Reactome.
DR   GO; GO:0019264; P:glycine biosynthetic process from serine; IEA:Ensembl.
DR   GO; GO:0006544; P:glycine metabolic process; IDA:UniProtKB.
DR   GO; GO:0006564; P:L-serine biosynthetic process; IEA:Ensembl.
DR   GO; GO:0006563; P:L-serine metabolic process; IDA:UniProtKB.
DR   GO; GO:0006730; P:one-carbon metabolic process; IDA:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0051289; P:protein homotetramerization; IEA:Ensembl.
DR   GO; GO:0070536; P:protein K63-linked deubiquitination; IMP:UniProtKB.
DR   GO; GO:0051262; P:protein tetramerization; IDA:UniProtKB.
DR   GO; GO:0034340; P:response to type I interferon; IDA:UniProtKB.
DR   GO; GO:0035999; P:tetrahydrofolate interconversion; IEA:UniProtKB-UniPathway.
DR   GO; GO:0046653; P:tetrahydrofolate metabolic process; IDA:UniProtKB.
DR   CDD; cd00378; SHMT; 1.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   HAMAP; MF_00051; SHMT; 1.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major_sub1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_sub2.
DR   InterPro; IPR001085; Ser_HO-MeTrfase.
DR   InterPro; IPR019798; Ser_HO-MeTrfase_PLP_BS.
DR   PANTHER; PTHR11680; PTHR11680; 1.
DR   Pfam; PF00464; SHMT; 1.
DR   PIRSF; PIRSF000412; SHMT; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   PROSITE; PS00096; SHMT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Membrane; Mitochondrion; Mitochondrion inner membrane;
KW   Mitochondrion nucleoid; Nucleus; One-carbon metabolism;
KW   Phosphoprotein; Pyridoxal phosphate; Reference proteome; Transferase;
KW   Transit peptide.
FT   TRANSIT       1     29       Mitochondrion.
FT   CHAIN        30    504       Serine hydroxymethyltransferase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000032562.
FT   MOD_RES     103    103       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     181    181       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     196    196       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     280    280       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000250|UniProtKB:P34896}.
FT   MOD_RES     297    297       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     356    356       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     464    464       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     469    469       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     470    470       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     474    474       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1     21       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043844.
FT   VAR_SEQ     199    208       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043088.
FT   CONFLICT    308    308       P -> L (in Ref. 8; AAA63258).
FT                                {ECO:0000305}.
FT   HELIX        49     52       {ECO:0000244|PDB:3OU5}.
FT   HELIX        54     69       {ECO:0000244|PDB:3OU5}.
FT   STRAND       70     72       {ECO:0000244|PDB:3OU5}.
FT   HELIX        82     88       {ECO:0000244|PDB:3OU5}.
FT   HELIX        91     93       {ECO:0000244|PDB:3OU5}.
FT   STRAND      103    107       {ECO:0000244|PDB:4PVF}.
FT   HELIX       111    126       {ECO:0000244|PDB:3OU5}.
FT   TURN        131    133       {ECO:0000244|PDB:3OU5}.
FT   STRAND      134    137       {ECO:0000244|PDB:3OU5}.
FT   HELIX       143    154       {ECO:0000244|PDB:3OU5}.
FT   STRAND      160    164       {ECO:0000244|PDB:4PVF}.
FT   HELIX       166    168       {ECO:0000244|PDB:4PVF}.
FT   HELIX       172    174       {ECO:0000244|PDB:4PVF}.
FT   HELIX       186    189       {ECO:0000244|PDB:4PVF}.
FT   STRAND      190    195       {ECO:0000244|PDB:4PVF}.
FT   TURN        199    201       {ECO:0000244|PDB:3OU5}.
FT   STRAND      202    204       {ECO:0000244|PDB:4PVF}.
FT   HELIX       206    216       {ECO:0000244|PDB:3OU5}.
FT   STRAND      219    223       {ECO:0000244|PDB:3OU5}.
FT   HELIX       234    244       {ECO:0000244|PDB:3OU5}.
FT   STRAND      247    251       {ECO:0000244|PDB:3OU5}.
FT   HELIX       253    255       {ECO:0000244|PDB:3OU5}.
FT   HELIX       256    260       {ECO:0000244|PDB:3OU5}.
FT   HELIX       267    269       {ECO:0000244|PDB:3OU5}.
FT   STRAND      272    280       {ECO:0000244|PDB:3OU5}.
FT   STRAND      288    293       {ECO:0000244|PDB:3OU5}.
FT   STRAND      295    299       {ECO:0000244|PDB:3OU5}.
FT   STRAND      306    308       {ECO:0000244|PDB:3OU5}.
FT   HELIX       312    319       {ECO:0000244|PDB:3OU5}.
FT   TURN        320    323       {ECO:0000244|PDB:3OU5}.
FT   HELIX       329    343       {ECO:0000244|PDB:3OU5}.
FT   HELIX       345    367       {ECO:0000244|PDB:3OU5}.
FT   HELIX       373    375       {ECO:0000244|PDB:3OU5}.
FT   STRAND      378    385       {ECO:0000244|PDB:3OU5}.
FT   HELIX       387    389       {ECO:0000244|PDB:3OU5}.
FT   HELIX       393    402       {ECO:0000244|PDB:3OU5}.
FT   STRAND      408    410       {ECO:0000244|PDB:3OU5}.
FT   STRAND      418    420       {ECO:0000244|PDB:3OU5}.
FT   STRAND      422    428       {ECO:0000244|PDB:3OU5}.
FT   HELIX       429    433       {ECO:0000244|PDB:3OU5}.
FT   HELIX       438    460       {ECO:0000244|PDB:3OU5}.
FT   HELIX       465    474       {ECO:0000244|PDB:3OU5}.
FT   HELIX       476    493       {ECO:0000244|PDB:3OU5}.
SQ   SEQUENCE   504 AA;  55993 MW;  7A13AF741C68FFD6 CRC64;
     MLYFSLFWAA RPLQRCGQLV RMAIRAQHSN AAQTQTGEAN RGWTGQESLS DSDPEMWELL
     QREKDRQCRG LELIASENFC SRAALEALGS CLNNKYSEGY PGKRYYGGAE VVDEIELLCQ
     RRALEAFDLD PAQWGVNVQP YSGSPANLAV YTALLQPHDR IMGLDLPDGG HLTHGYMSDV
     KRISATSIFF ESMPYKLNPK TGLIDYNQLA LTARLFRPRL IIAGTSAYAR LIDYARMREV
     CDEVKAHLLA DMAHISGLVA AKVIPSPFKH ADIVTTTTHK TLRGARSGLI FYRKGVKAVD
     PKTGREIPYT FEDRINFAVF PSLQGGPHNH AIAAVAVALK QACTPMFREY SLQVLKNARA
     MADALLERGY SLVSGGTDNH LVLVDLRPKG LDGARAERVL ELVSITANKN TCPGDRSAIT
     PGGLRLGAPA LTSRQFREDD FRRVVDFIDE GVNIGLEVKS KTAKLQDFKS FLLKDSETSQ
     RLANLRQRVE QFARAFPMPG FDEH
//
